In Vitro Titan Cell Generation in Cryptococcus neoformans and Automated Cell Size Measurements.


Journal

Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969

Informations de publication

Date de publication:
2024
Historique:
medline: 17 5 2024
pubmed: 17 5 2024
entrez: 17 5 2024
Statut: ppublish

Résumé

A special feature of the human fungal pathogen Cryptococcus neoformans is its morphological changes triggered by the interaction with the host. During infection, a specific increase in cell size is observed, particularly in lung tissue, from a typical cell size of 5-7 μm cells to cells larger than 10 μm, dubbed titan cells (TCs). However, the study of this specific cell subpopulation was, until now, only possible via recovery of TCs from lungs of mice during experimental infections where stable and reproducible generation of TCs occurs.The protocol described here generates TCs using in vitro conditions and measures cell size using a rapid, automated method. TC generation in vitro is robust and reproducible, generating yeast cells harboring the same characteristics of TCs generated in vivo.

Identifiants

pubmed: 38758332
doi: 10.1007/978-1-0716-3722-7_26
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

385-391

Informations de copyright

© 2024. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Rajasingham R, Govender NP, Jordan A et al (2022) The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis. Lancet Infect Dis 17:873–881. https://doi.org/10.1016/s1473-3099(22)00499-6
doi: 10.1016/s1473-3099(22)00499-6
Park BJ, Wannemuehler KA, Marston BJ et al (2009) Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23:525–530. https://doi.org/10.1097/qad.0b013e328322ffac
doi: 10.1097/qad.0b013e328322ffac pubmed: 19182676
Alanio A, Vernel-Pauillac F, Sturny-Leclère A et al (2015) Cryptococcus neoformans host adaptation: toward biological evidence of dormancy. MBio 6:e02580–e02514. https://doi.org/10.1128/mbio.02580-14
doi: 10.1128/mbio.02580-14 pubmed: 25827423 pmcid: 4453510
Choi J, Vogl AW, Kronstad JW (2012) Regulated expression of cyclic AMP-dependent protein kinase a reveals an influence on cell size and the secretion of virulence factors in Cryptococcus neoformans. Mol Microbiol 85:700–715. https://doi.org/10.1111/j.1365-2958.2012.08134.x
doi: 10.1111/j.1365-2958.2012.08134.x pubmed: 22717009
Franzot SP, Mukherjee J, Cherniak R et al (1998) Microevolution of a standard strain of Cryptococcus neoformans resulting in differences in virulence and other phenotypes. Infect Immun 66:89–97
doi: 10.1128/IAI.66.1.89-97.1998 pubmed: 9423844 pmcid: 107863
Hu G, Cheng P, Sham A et al (2008) Metabolic adaptation in Cryptococcus neoformans during early murine pulmonary infection. Mol Microbiol 69:1456–1475. https://doi.org/10.1111/j.1365-2958.2008.06374.x
doi: 10.1111/j.1365-2958.2008.06374.x pubmed: 18673460 pmcid: 2730461
Gerstein AC, Nielsen K (2016) It’s not all about us: evolution and maintenance of Cryptococcus virulence requires selection outside the human host. Yeast 34:143–154. https://doi.org/10.1002/yea.3222
doi: 10.1002/yea.3222
Brown SM, Campbell LT, Lodge JK (2007) Cryptococcus neoformans, a fungus under stress. Curr Opin Microbiol 10:320–325. https://doi.org/10.1016/j.mib.2007.05.014
doi: 10.1016/j.mib.2007.05.014 pubmed: 17707685 pmcid: 2570326
Zaragoza O, Rodrigues ML, Jesus MD et al (2009) The capsule of the fungal pathogen Cryptococcus neoformans. Adv Appl Microbiol 68:133–216. https://doi.org/10.1016/s0065-2164(09)01204-0
doi: 10.1016/s0065-2164(09)01204-0 pubmed: 19426855 pmcid: 2739887
Kronstad J, Saikia S, Nielson ED et al (2012) Adaptation of Cryptococcus neoformans to mammalian hosts: integrated regulation of metabolism and virulence. Eukaryot Cell 11:109–118. https://doi.org/10.1128/ec.05273-11
doi: 10.1128/ec.05273-11 pubmed: 22140231 pmcid: 3272904
Rodrigues ML, Nakayasu ES, Oliveira DL et al (2008) Extracellular vesicles produced by Cryptococcus neoformans contain protein components associated with virulence. Eukaryot Cell 7:58–67. https://doi.org/10.1128/ec.00370-07
doi: 10.1128/ec.00370-07 pubmed: 18039940
Fries BC, Taborda CP, Serfass E et al (2001) Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infection. J Clin Invest 108:1639–1648. https://doi.org/10.1172/jci13407
doi: 10.1172/jci13407 pubmed: 11733559 pmcid: 200988
Bouklas T, Pechuan X, Goldman DL et al (2013) Old Cryptococcus neoformans cells contribute to virulence in chronic cryptococcosis. MBio 4:e00455–e00413. https://doi.org/10.1128/mbio.00455-13
doi: 10.1128/mbio.00455-13 pubmed: 23943761 pmcid: 3747583
Hommel B, Sturny-Leclère A, Volant S et al (2019) Cryptococcus neoformans resists to drastic conditions by switching to viable but non-culturable cell phenotype. PLoS Pathog 15:e1007945. https://doi.org/10.1371/journal.ppat.1007945
doi: 10.1371/journal.ppat.1007945 pubmed: 31356623 pmcid: 6687208
Zaragoza O, Nielsen K (2013) Titan cells in Cryptococcus neoformans: cells with a giant impact. Curr Opin Microbiol 16:409–413. https://doi.org/10.1016/j.mib.2013.03.006
doi: 10.1016/j.mib.2013.03.006 pubmed: 23588027 pmcid: 3723695
Zaragoza O, García-Rodas R, Nosanchuk JD et al (2010) Fungal cell gigantism during mammalian infection. PLoS Pathog 6:e1000945. https://doi.org/10.1371/journal.ppat.1000945
doi: 10.1371/journal.ppat.1000945 pubmed: 20585557 pmcid: 2887474
Love GL, Boyd GD, Greer DL (1985) Large Cryptococcus neoformans isolated from brain abscess. J Clin Microbiol 22:1068–1070
doi: 10.1128/jcm.22.6.1068-1070.1985 pubmed: 3905847 pmcid: 271885
Cruickshank JG, Cavill R, Jelbert M (1973) Cryptococcus neoformans of unusual morphology. Appl Microbiol 25:309–312
doi: 10.1128/am.25.2.309-312.1973 pubmed: 4121033 pmcid: 380794
García-Rodas R, Casadevall A, Rodríguez-Tudela JL et al (2011) Cryptococcus neoformans capsular enlargement and cellular gigantism during galleria mellonella infection. PLoS One 6:e24485. https://doi.org/10.1371/journal.pone.0024485
doi: 10.1371/journal.pone.0024485 pubmed: 21915338 pmcid: 3168503
Dambuza IM, Drake T, Chapuis A et al (2018) The Cryptococcus neoformans titan cell is an inducible and regulated morphotype underlying pathogenesis. PLoS Pathog 14:e1006978. https://doi.org/10.1371/journal.ppat.1006978
doi: 10.1371/journal.ppat.1006978 pubmed: 29775474 pmcid: 5959070
Hommel B, Mukaremera L, Cordero RJB et al (2018) Titan cells formation in Cryptococcus neoformans is finely tuned by environmental conditions and modulated by positive and negative genetic regulators. PLoS Pathog 14:e1006982. https://doi.org/10.1371/journal.ppat.1006982
doi: 10.1371/journal.ppat.1006982 pubmed: 29775480 pmcid: 5959062
Trevijano-Contador N, de Oliveira HC, García-Rodas R et al (2018) Cryptococcus neoformans can form titan-like cells in vitro in response to multiple signals. PLoS Pathog 14:e1007007. https://doi.org/10.1371/journal.ppat.1007007
doi: 10.1371/journal.ppat.1007007 pubmed: 29775477 pmcid: 5959073
Chrisman CJ, Albuquerque P, Guimaräes AJ et al (2011) Phospholipids trigger Cryptococcus neoformans capsular enlargement during interactions with amoebae and macrophages. PLoS Pathog 7:e1002047. https://doi.org/10.1371/journal.ppat.1002047
doi: 10.1371/journal.ppat.1002047 pubmed: 21637814 pmcid: 3102711
Okagaki LH, Nielsen K (2012) Titan cells confer protection from phagocytosis in Cryptococcus neoformans infections. Eukaryot Cell 11:820–826. https://doi.org/10.1128/ec.00121-12
doi: 10.1128/ec.00121-12 pubmed: 22544904 pmcid: 3370461
Gerstein AC, Fu MS, Mukaremera L et al (2015) Polyploid titan cells produce haploid and aneuploid progeny to promote stress adaptation. MBio 6:e01340–e01315. https://doi.org/10.1128/mbio.01340-15
doi: 10.1128/mbio.01340-15 pubmed: 26463162 pmcid: 4620463
Okagaki LH, Strain AK, Nielsen JN et al (2010) Cryptococcal cell morphology affects host cell interactions and pathogenicity. PLoS Pathog 6:e1000953. https://doi.org/10.1371/journal.ppat.1000953
doi: 10.1371/journal.ppat.1000953 pubmed: 20585559 pmcid: 2887476
de Chaumont F, Dallongeville S, Chenouard N et al (2012) Icy: an open bioimage informatics platform for extended reproducible research. Nat Methods 9:690–696. https://doi.org/10.1038/nmeth.2075
doi: 10.1038/nmeth.2075 pubmed: 22743774
Dufour A, Meas-Yedid V, Grassart A et al (2008) Automated quantification of cell endocytosis using active contours and wavelets. 2008 19th Int Conf Pattern Recognit 1–4. https://doi.org/10.1109/icpr.2008.4761748

Auteurs

Benjamin Hommel (B)

Translational Mycology Research Group, Institut Pasteur, Université Paris Cité, Centre National de Référence Mycoses Invasives et Antifongiques, Département de Mycologie, Paris, France.

Aude Sturny-Leclère (A)

Institut Pasteur, Université Paris Cité,National Reference Center for Invasive Mycoses and Antifungals, Paris, France.

Alexandre Alanio (A)

Translational Mycology Research Group, Institut Pasteur, Université Paris Cité, Centre National de Référence Mycoses Invasives et Antifongiques, Département de Mycologie, Paris, France. alexandre.alanio@pasteur.fr.
Laboratoire de parasitologie-mycologie, AP-HP, Hôpital Saint-Louis, Paris, France. alexandre.alanio@pasteur.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH